piracetam has been researched along with Disease Exacerbation in 21 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam was well tolerated." | 6.74 | Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009) |
| "Late Onset Myoclonic Epilepsy in Down Syndrome (LOMEDS) is a recognized entity usually preceded by cognitive deterioration." | 5.36 | Improvement of myoclonic epilepsy in Down syndrome treated with levetiracetam. ( Amina, S; Koubeissi, M; Sangani, M; Shahid, A, 2010) |
| "Levetiracetam was well tolerated." | 2.74 | Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. ( Bedlack, RS; Hawes, J; Heydt, D; Pastula, DM, 2009) |
| "Piracetam was well tolerated and adverse effects were few, mild, and transient." | 2.69 | Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. ( Hakamies, L; Koskiniemi, M; Lamusuo, S; Taalas, J; Van Vleymen, B, 1998) |
| " Two double-blind comparisons with placebo provided results which allow recommendations for the dosage and usage of piracetam in cortical myoclonus." | 2.40 | Piracetam in the treatment of cortical myoclonus. ( Genton, P; Guerrini, R; Remy, C, 1999) |
| "Levetiracetam was the most commonly used initial medication, with the majority (73%) of patients treated achieving partial or complete seizure control." | 1.46 | The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy. ( Chemali, Z; Gholipour, T; Mitchell, S; Sarkis, RA, 2017) |
| "West syndrome is an age-dependent epilepsy with onset peak in the first year of life whose aetiology may be symptomatic or cryptogenic." | 1.39 | West syndrome followed by juvenile myoclonic epilepsy: a coincidental occurrence? ( Fontana, A; Giordano, G; Mangano, GR; Mangano, S; Nardello, R; Spitaleri, C; Tripi, G, 2013) |
| "Levetiracetam (LEV) is an established anticonvulsant with numerous mechanisms of action." | 1.38 | Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis. ( Ellrichmann, G; Faustmann, PM; Gold, R; Haghikia, A; Thöne, J, 2012) |
| "Late Onset Myoclonic Epilepsy in Down Syndrome (LOMEDS) is a recognized entity usually preceded by cognitive deterioration." | 1.36 | Improvement of myoclonic epilepsy in Down syndrome treated with levetiracetam. ( Amina, S; Koubeissi, M; Sangani, M; Shahid, A, 2010) |
| "A patient presented myoclonus involving all parts of the body after laryngospasm." | 1.32 | [Favorable course of Lance-Adams postanoxic action myoclonus]. ( Benabdejlil, M; Benomar, A; Chkili, T; Errguig, L; Messouak, W; Regragui, W; Yahyaoui, M, 2003) |
| "Treatment with piracetam was initiated at a dose of 3." | 1.31 | Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy. ( Andermann, E; Andermann, F; D'Agostino, D; Dubeau, F; Fedi, M; Reutens, D, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furtado, I | 1 |
| Gonçalves, F | 1 |
| Gonçalves, J | 1 |
| Neves, J | 1 |
| Lv, Y | 1 |
| Zhang, N | 1 |
| Liu, C | 1 |
| Shi, M | 1 |
| Sun, L | 1 |
| Mangano, S | 1 |
| Nardello, R | 1 |
| Tripi, G | 1 |
| Giordano, G | 1 |
| Spitaleri, C | 1 |
| Mangano, GR | 1 |
| Fontana, A | 1 |
| Cai, X | 1 |
| Bhattacharyya, S | 1 |
| Plitt, A | 1 |
| Raibagkar, P | 1 |
| LaBuzetta, JN | 1 |
| Schleicher, SM | 1 |
| Munshi, NC | 1 |
| Klein, JP | 1 |
| Gholipour, T | 1 |
| Mitchell, S | 1 |
| Sarkis, RA | 1 |
| Chemali, Z | 1 |
| Batysheva, TT | 2 |
| Bagir', LV | 2 |
| Kostenko, EV | 2 |
| Artemova, IIu | 1 |
| Bdovichenko, TV | 1 |
| Gazhula, PA | 1 |
| Zhuravleva, EIu | 1 |
| Ismailov, AM | 2 |
| Lisenker, LN | 2 |
| Nesterova, OV | 2 |
| Otcheskaia, OV | 1 |
| Rotor, LD | 2 |
| Khozova, AA | 2 |
| Boĭko, AN | 2 |
| Bedlack, RS | 1 |
| Pastula, DM | 1 |
| Hawes, J | 1 |
| Heydt, D | 1 |
| Artemova, IY | 1 |
| Vdovichenko, TV | 1 |
| Ganzhula, PA | 1 |
| Zhuravleva, EY | 1 |
| Otcheskaya, OV | 1 |
| Singh, S | 1 |
| Schwankhaus, J | 1 |
| Ishimaru, Y | 1 |
| Chiba, S | 1 |
| Serikawa, T | 1 |
| Sasa, M | 1 |
| Inaba, H | 1 |
| Tamura, Y | 1 |
| Ishimoto, T | 1 |
| Takasaki, H | 1 |
| Sakamoto, K | 1 |
| Yamaguchi, K | 1 |
| Sangani, M | 1 |
| Shahid, A | 1 |
| Amina, S | 1 |
| Koubeissi, M | 1 |
| Robins, A | 1 |
| Patel, M | 1 |
| Azim, A | 1 |
| Farooque, P | 1 |
| Goraya, J | 1 |
| Valencia, I | 1 |
| Carvalho, KS | 1 |
| Hardison, HH | 1 |
| Legido, A | 1 |
| Khurana, DS | 1 |
| Thöne, J | 1 |
| Ellrichmann, G | 1 |
| Faustmann, PM | 1 |
| Gold, R | 1 |
| Haghikia, A | 1 |
| Errguig, L | 1 |
| Benomar, A | 1 |
| Messouak, W | 1 |
| Regragui, W | 1 |
| Benabdejlil, M | 1 |
| Yahyaoui, M | 1 |
| Chkili, T | 1 |
| Zaffanello, M | 1 |
| Zamboni, G | 1 |
| García Callejo, FJ | 1 |
| Ramírez Sabio, JB | 1 |
| Conill Tobías, N | 1 |
| Sebastian Gil, E | 1 |
| Orts Alborch, MH | 1 |
| Marco Algarra, J | 1 |
| Bugrova, SG | 1 |
| Novikov, AE | 1 |
| Koskiniemi, M | 1 |
| Van Vleymen, B | 1 |
| Hakamies, L | 1 |
| Lamusuo, S | 1 |
| Taalas, J | 1 |
| Genton, P | 1 |
| Guerrini, R | 1 |
| Remy, C | 1 |
| Fedi, M | 1 |
| Reutens, D | 1 |
| Dubeau, F | 1 |
| Andermann, E | 1 |
| D'Agostino, D | 1 |
| Andermann, F | 1 |
1 review available for piracetam and Disease Exacerbation
| Article | Year |
|---|---|
Piracetam in the treatment of cortical myoclonus.
Topics: Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Humans; Myoclonus; Neur | 1999 |
3 trials available for piracetam and Disease Exacerbation
| Article | Year |
|---|---|
Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.
Topics: Adult; Aged; Anticonvulsants; Disease Progression; Humans; Levetiracetam; Middle Aged; Motor Neuron | 2009 |
[Immunomediation or hyperviscosity in rapidly progressive sensorineural hearing loss. A therapeutic approach].
Topics: Adrenal Cortex Hormones; Adult; Blood Viscosity; Disease Progression; Double-Blind Method; Female; H | 2006 |
Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo.
Topics: Activities of Daily Living; Administration, Oral; Adolescent; Adult; Cross-Over Studies; Disease Pro | 1998 |
17 other studies available for piracetam and Disease Exacerbation
| Article | Year |
|---|---|
Continuous subcutaneous levetiracetam in end-of-life care.
Topics: Aged, 80 and over; Anticonvulsants; Dementia, Vascular; Disease Progression; Female; Humans; Infusio | 2018 |
Occipital epilepsy versus progressive myoclonic epilepsy in a patient with continuous occipital spikes and photosensitivity in electroencephalogram: A case report.
Topics: Anticonvulsants; Atrophy; Cerebral Cortex; Diagnosis, Differential; Disease Progression; Electroence | 2018 |
West syndrome followed by juvenile myoclonic epilepsy: a coincidental occurrence?
Topics: Adolescent; Brain; Disease Progression; Humans; Infant; Levetiracetam; Magnetic Resonance Imaging; M | 2013 |
Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma.
Topics: Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents; Biomarkers, Tumor; Bortezomib; Brai | 2016 |
The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy.
Topics: Adult; Anticonvulsants; Dementia; Disease Progression; Down Syndrome; Epilepsy; Female; Humans; Leve | 2017 |
[The use of memotropil for treatment of mild cognitive impairment in out-patients with progressive chronic cerebrovascular disorders].
Topics: Aged; Ambulatory Care; Cerebrovascular Disorders; Chronic Disease; Cognition Disorders; Disease Prog | 2008 |
Experience of the out-patient use of memotropil in the treatment of cognitive disorders in patients with chronic progressive cerebrovascular disorders.
Topics: Aged; Ambulatory Care; Cerebrovascular Disorders; Chronic Disease; Cognition Disorders; Disease Prog | 2009 |
Olfactory disturbance in Parkinson disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain; | 2009 |
Effects of levetiracetam on hippocampal kindling in Noda epileptic rats.
Topics: Animals; Anticonvulsants; Brain Stem; Disease Models, Animal; Disease Progression; Drug Administrati | 2010 |
Improvement of myoclonic epilepsy in Down syndrome treated with levetiracetam.
Topics: Adult; Alzheimer Disease; Anticonvulsants; Disease Progression; Dose-Response Relationship, Drug; Do | 2010 |
A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy.
Topics: Aged; Anticonvulsants; Cognition; Disease Progression; Drug-Related Side Effects and Adverse Reactio | 2012 |
Early-onset childhood absence epilepsy: is it a distinct entity?
Topics: Age Factors; Age of Onset; Anticonvulsants; Child; Child Development; Child, Preschool; Cohort Studi | 2011 |
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Disease Models, Animal; Disease P | 2012 |
[Favorable course of Lance-Adams postanoxic action myoclonus].
Topics: Anticonvulsants; Disease Progression; Electroencephalography; Electrophysiology; Humans; Hypoxia, Br | 2003 |
Therapeutic approach in a case of Pearson's syndrome.
Topics: Acidosis, Lactic; Bone Marrow Diseases; Calcium; Child, Preschool; Disease Progression; DNA, Mitocho | 2005 |
[The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
Topics: Adult; Cerebrovascular Disorders; Chronic Disease; Cognition; Cognition Disorders; Disease Progressi | 2007 |
Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Disability Evaluation; Disease Progression; Dose-Response Relati | 2001 |